Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Microbiol Immunol Infect ; 52(6): 880-887, 2019 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-31732418

RESUMEN

BACKGROUND: Influenza is a major cause of acute respiratory infection burden worldwide, leading to many hospitalizations. An annual influenza vaccine is believed to be the best way to prevent influenza-related illnesses. We focused on the efficacies of other possible preventive measures such as increasing sun exposure time and dietary supplements to prevent these illnesses. METHODS: We conducted a matched-pair case-control study along with the Taiwan Pediatric Infectious Disease Alliance. We included influenza-related hospitalized patients with age ranging from 6 months to 5 years during the 2012-2013, 2013-2014, 2014-2015, and 2015-2016 influenza seasons. The controls were comparable to cases in age, sex, and residential area and had no influenza-related hospitalization records in the same season. We extracted data from vaccination histories and got the patients' guardians to complete questionnaires. Data were analyzed using conditional logistic regression. RESULTS: We enrolled 1514 children (421 influenza-infected cases and 1093 controls) in the study. We found seasonal influenza vaccination to be an independent protective factor against hospitalizations owing to influenza [p < 0.01; odds ratio (OR), 0.427; 95% confidence interval (CI), 0.306-0.594]. Children with mean sun exposure time of >7 h/week had a significantly lower risk of influenza-related hospitalizations than those with the mean sun exposure time of ≤7 h/week (p < 0.05; OR, 0.667; 95% CI, 0.491-0.906). CONCLUSIONS: Seasonal influenza vaccination effectively prevents influenza-related hospitalizations in children aged ≤5 years. Besides, >7 h of sun exposure/week may also be associated with lower risk of influenza-related hospitalizations in children.


Asunto(s)
Hospitalización/estadística & datos numéricos , Vacunas contra la Influenza/administración & dosificación , Gripe Humana/diagnóstico , Luz Solar , Estudios de Casos y Controles , Preescolar , Femenino , Humanos , Lactante , Gripe Humana/inmunología , Modelos Logísticos , Masculino , Oportunidad Relativa , Factores Protectores , Estaciones del Año , Taiwán , Vacunación/estadística & datos numéricos
2.
J Microbiol Immunol Infect ; 52(2): 225-232, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-30528336

RESUMEN

BACKGROUND: Dengue is an important mosquito-borne tropical viral disease and dual infection, though rare, has been regarded as a risk factor for severe disease and mortality. However, few studies focused on bloodstream infections (BSIs) and empirical antibiotic therapy rarely addressed. METHODS: Dengue patients with concurrent or subsequent BSIs between July 1 and December 31, 2015 were included. Clinical information, laboratory data, and drug susceptibility data were collected. RESULTS: Totally 80 patients, with an in-hospital mortality rate of 32.5%, were included and categorized into three groups. 32 patients in Group I (BSI onset within 48 h after admission), 32 in Group II (between 48 h and one week), and 16 in Group III (more than one week). Patients in Group I were older (mean age: 75.6 vs. 72.6 or 69.6 years; P = 0.01) and had a higher Charlson comorbidity index (3.1 vs. 1.8 or 1.9; P = 0.02) than those in Group II or III. Streptococcus species (28.9%, 11/38) and Escherichia coli (23.7%, 9/38) were major pathogens in Group I. Enterobacteriaceae (38.2%, 13/34) isolates predominated in Group II. Fatal patients more often received inappropriate empirical antibiotic than the survivors (61.5% vs. 35.2%; P = 0.03). According to susceptibility data, pathogens in Group I and II shared similar susceptibility profiles, and levofloxacin, cefepime, or piperacillin/tazobactam, can be empirically prescribed for those hospitalized within one week. CONCLUSIONS: BSI pathogens vary among dengue patients. For adults with dengue and suspected BSI hospitalized within one week, empirical antimicrobial agents are recommended.


Asunto(s)
Bacteriemia/complicaciones , Bacteriemia/tratamiento farmacológico , Bacteriemia/microbiología , Coinfección/tratamiento farmacológico , Dengue/complicaciones , Anciano , Anciano de 80 o más Años , Antibacterianos/uso terapéutico , Candidemia/complicaciones , Candidemia/tratamiento farmacológico , Candidemia/microbiología , Cefepima/uso terapéutico , Enterobacteriaceae/aislamiento & purificación , Enterobacteriaceae/patogenicidad , Infecciones por Enterobacteriaceae/sangre , Infecciones por Enterobacteriaceae/tratamiento farmacológico , Infecciones por Enterobacteriaceae/microbiología , Escherichia coli/aislamiento & purificación , Escherichia coli/patogenicidad , Infecciones por Escherichia coli/tratamiento farmacológico , Femenino , Hospitales , Humanos , Levofloxacino/uso terapéutico , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Mortalidad , Combinación Piperacilina y Tazobactam/uso terapéutico , Estudios Retrospectivos , Factores de Riesgo , Infecciones Estafilocócicas/tratamiento farmacológico , Streptococcus/aislamiento & purificación , Streptococcus/patogenicidad , Taiwán
3.
Sci Rep ; 7(1): 12264, 2017 09 25.
Artículo en Inglés | MEDLINE | ID: mdl-28947773

RESUMEN

Enterovirus 71 (EV71) infection is endemic in the Asia-Pacific region. No specific antiviral drug has been available to treat EV71 infection. Melissa officinalis (MO) is a medicinal plant with long history of usage in the European and Middle East. We investigated whether an aqueous solution of concentrated methanolic extract (MOM) possesses antiviral activity. MOM inhibited plaque formation, cytopathic effect, and viral protein synthesis in EV71-infected cells. Using spectral techniques, we identified rosmarinic acid (RA) as a biologically active constituent of MOM. RA reduced viral attachment and entry; cleavage of eukaryotic translation initiation factor 4 G (eIF4G); reactive oxygen species (ROS) generation; and translocation of heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) from nucleus to cytoplasm. It alleviated EV71-induced hyperphosphorylation of p38 kinase and EPS15. RA is likely to suppress ROS-mediated p38 kinase activation, and such downstream molecular events as hnRNP A1 translocation and EPS15-regulated membrane trafficking in EV71-infected cells. These findings suggest that MO and its constituent RA possess anti-EV71 activities, and may serve as a candidate drug for therapeutic and prophylactic uses against EV71 infection.


Asunto(s)
Antivirales/farmacología , Cinamatos/farmacología , Depsidos/farmacología , Enterovirus Humano A/efectos de los fármacos , Melissa/química , Extractos Vegetales/farmacología , Internalización del Virus/efectos de los fármacos , Antivirales/aislamiento & purificación , Línea Celular , Cinamatos/aislamiento & purificación , Efecto Citopatogénico Viral , Depsidos/aislamiento & purificación , Enterovirus Humano A/fisiología , Humanos , Extractos Vegetales/aislamiento & purificación , Ensayo de Placa Viral , Ácido Rosmarínico
4.
Sci Rep ; 7(1): 935, 2017 04 20.
Artículo en Inglés | MEDLINE | ID: mdl-28428548

RESUMEN

No effective drug is currently available for treatment of enterovirus 71 (EV71) infection. Schizonepeta tenuifolia Briq. (ST) has been used as a herbal constituent of traditional Chinese medicine. We studied whether the aqueous extract of Schizonepeta tenuifolia Briq (STE) has antiviral activity. STE inhibited replication of EV71, as evident by its ability to diminish plaque formation and cytopathic effect induced by EV71, and to inhibit the synthesis of viral RNA and protein. Moreover, daily single-dose STE treatment significantly improved the survival of EV71-infected mice, and ameliorated the symptoms. Mechanistically, STE exerts multiple effects on enteroviral infection. Treatment with STE reduced viral attachment and entry; the cleavage of eukaryotic translation initiation factor 4 G (eIF4G) by EV71 protease, 2Apro; virus-induced reactive oxygen species (ROS) formation; and relocation of heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) from the nucleus to the cytoplasm. It was accompanied by a decline in EV71-associated hyperphosphorylation of p38 kinase and EPS15. It is plausible that STE may inhibit ROS-induced p38 kinase activation, and subsequent hnRNP A1 relocation and EPS15-mediated membrane trafficking in infected cells. These findings suggest that STE possesses anti-EV71 activities, and may serve as health food or candidate antiviral drug for protection against EV71.


Asunto(s)
Antivirales/uso terapéutico , Enterovirus Humano A/efectos de los fármacos , Infecciones por Enterovirus/tratamiento farmacológico , Lamiaceae/química , Extractos Vegetales/uso terapéutico , Proteínas Adaptadoras Transductoras de Señales/metabolismo , Animales , Antivirales/farmacología , Línea Celular Tumoral , Chlorocebus aethiops , Enterovirus Humano A/fisiología , Infecciones por Enterovirus/virología , Factor 4G Eucariótico de Iniciación/metabolismo , Ribonucleoproteína Nuclear Heterogénea A1/metabolismo , Humanos , Ratones , Ratones Endogámicos ICR , Extractos Vegetales/farmacología , Especies Reactivas de Oxígeno/metabolismo , Células Vero , Replicación Viral , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo
5.
J Nurs Res ; 21(4): 252-60, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24241274

RESUMEN

BACKGROUND: Childhood fever is a commonly treated condition in medical settings. Many studies around the world have reported on the phenomenon of parental fever phobia. Studies of parental knowledge regarding childhood fever are lacking in Taiwan. PURPOSE: This study explores parental knowledge, concerns, and management of childhood fever and their correlates in Taiwan. METHODS: This study used a cross-sectional survey and self-administered questionnaire. Six hundred forty-nine parents were recruited as participants from pediatric clinics and kindergartens in southern Taiwan. RESULTS: Nearly half (47.2%) of participants incompletely understood the healthcare information about childhood fever provided by physicians and nurses. Furthermore, 41.6% of parents were dissatisfied with the information provided. The median score of parental knowledge was 10 (interquartile range [IQR] = [8, 12] out of a maximum of 23). Parent gender, religion, education level, and occupation were independent predictors of knowledge scores. Parents who were never or sometimes concerned about childhood fever had significantly higher knowledge scores than those who were always concerned about childhood fever (median knowledge score: 11, IQR = [9, 13] vs. 10, IQR = [8, 11]). Most parents followed Western medical advice to manage childhood fever; however, 31.1% of parents combined this with traditional folk treatments. Levels of concern among parents included 86.6% of parents who frequently or always worried about their children's fever. Fever-induced anxiety was reported by 68.8% of the parents. CONCLUSIONS/IMPLICATIONS FOR PRACTICE: Participants' lack of fever-related knowledge was because, in part, of either their not understanding or their dissatisfaction with provided information. The higher level of concern compared with other countries and studies indicates that parents in Taiwan need appropriate information about fever management to alleviate their concerns and guide them in caring for their febrile children.


Asunto(s)
Fiebre/terapia , Conocimientos, Actitudes y Práctica en Salud , Padres/psicología , Adulto , Preescolar , Estudios Transversales , Femenino , Humanos , Lactante , Masculino , Satisfacción del Paciente , Encuestas y Cuestionarios , Taiwán
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA